Investment Thesis
EMED is a financially distressed micro-cap company with severe operational and balance sheet deterioration. The company operates with significant losses across all profitability metrics, negative stockholders' equity of -$4.0M, and critically depleted liquidity with a current ratio of 0.07x. Negative operating cash flow and continued operating losses indicate the business is not self-sustaining.
Strengths
- Strong gross margin of 73.9% indicates underlying product demand and pricing power if operational losses can be controlled
- Revenue growth of 17.3% YoY shows market demand exists for the company's medical devices
- Minimal capital expenditure requirements suggest asset-light business model
Risks
- Negative stockholders' equity of -$4.0M indicates technical insolvency and high bankruptcy risk
- Critical liquidity crisis with only $34.8K cash against $4.6M total liabilities and current ratio of 0.07x - cannot meet near-term obligations
- Massive operating losses (-$787.8K) and net loss (-$1.3M) far exceed revenue; operating margin of -138.1% indicates fundamental business model failure
- Negative operating cash flow of -$80.3K indicates cash burn despite positive gross profit, suggesting uncontrolled SG&A or other operating expenses
- Long-term debt of $1.6M with negative equity creates debt covenant risks and refinancing concerns
- No insider buying activity in last 90 days signals lack of management confidence
Key Metrics to Watch
- Cash position and burn rate - company may face liquidity crisis within months
- Operating expense reduction and path to operating cash flow positivity
- Ability to restructure debt or raise capital to address negative equity position
Financial Metrics
Revenue
570.4K
Net Income
-1.3M
EPS (Diluted)
$0.00
Free Cash Flow
-80.3K
Total Assets
568.8K
Cash
34.8K
Profitability Ratios
Gross Margin
73.9%
Operating Margin
-138.1%
Net Margin
-233.1%
ROE
N/A
ROA
-233.8%
FCF Margin
-14.1%
Balance Sheet & Liquidity
Current Ratio
0.07x
Quick Ratio
0.06x
Debt/Equity
N/A
Debt/Assets
804.1%
Interest Coverage
-6.70x
Long-term Debt
1.6M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-03-24T06:34:11.605459 |
Data as of: 2024-09-30 |
Powered by Claude AI